March 20, 2019
Decibel Therapeutics Selects 4G Clinical as Preferred RTSM Provider
Written by: Amy Ripston
February 12, 2019
Decibel Therapeutics Selects 4G Clinical as Preferred RTSM Provider - Partnership Enables Complex Trial Designs for the Development of Novel Therapies
WELLESLEY, Mass., Feb. 12, 2019 /PRNewswire/ -- 4G Clinical today announced a partnership with Decibel Therapeutics to enable complex trial designs for the development of novel therapies for hearing and balance disorders. As part of this collaboration, 4G Clinical has been selected as a preferred RTSM provider for Decibel's clinical development programs.
"The complexity of today's trials requires an RTSM solution that is flexible enough to adapt as trials evolve," says Heather Wolff, Senior Director, Clinical Development Operations at Decibel Therapeutics. "4G Clinical's modern technology is best-in-class and the tool that will be the best fit for an emerging biotech company such as Decibel. We believe that 4G's solution and expert staff are exactly what we have been seeking in an RTSM vendor partner."
"The biotech community is making critical advancements in science, and our goal is to make it easier for them to let the science take the lead in their trials," says David Kelleher, CEO of 4G Clinical. "We are excited to partner with Decibel Therapeutics to enable the complex trials that are necessary to benefit patients."
The Decibel – 4G Clinical partnership is a testament to the commitment of both organizations to drive operational excellence in clinical trials and bring much needed medications to the market.
About Decibel Therapeutics
Decibel Therapeutics has established the world's first comprehensive drug discovery, development, and translational research platform to discover and develop therapeutics to protect, repair, and restore hearing. To serve the over half a billion people globally living with hearing loss and related disorders, Decibel is committed to creating a world in which the benefits and joys of hearing are available to all. Decibel is headquartered in Boston, Mass. For more information about Decibel Therapeutics, please visit www.decibeltx.com or follow @DecibelTx on Twitter.
About 4G Clinical
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. Learn more about 4G Clinical at www.4gclinical.com.
Tag(s): Press Releases
Related Blog Posts HeadlineView All Blog Posts
January 30, 2019
EPS Corporation Selects 4G Clinical as IRT/RTSM Provider for Multinational Clinical TrialsRead More
November 6, 2017
4G Clinical Named to Pharma Top Technology Solution ProvidersRead More
October 22, 2019